This topic contains a solution. Click here to go to the answer

Author Question: During visual examination of an elderly patient, the physician notes progressive deterioration of ... (Read 16 times)

savannahhooper

  • Hero Member
  • *****
  • Posts: 576
During visual examination of an elderly patient, the physician notes progressive deterioration of the macula lutea. He informs the patient she will eventually experience loss of visual focus. The correct abbreviation for this condition is:
 
  A) ENT
  B) VF
  C) AMD
  D) ML

Question 2

The medical term that means difficult breathing is:
 
  A) tachypnea
  B) apnea
  C) dyspnea
  D) hyperpnea



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Pswine

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

C
Explanation: AMD stands for age-related macular degeneration.

Answer to Question 2

C
Explanation: The prefix dys- means difficult or bad, and the suffix -pnea, breathing. Not to be confused with apnea, where the prefix a- indicates the meaning without breathing.




savannahhooper

  • Member
  • Posts: 576
Reply 2 on: Jun 27, 2018
YES! Correct, THANKS for helping me on my review


aruss1303

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library